Stockreport

Is There An Opportunity With Teva Pharmaceutical Industries Limited's (NYSE:TEVA) 45% Undervaluation? [Yahoo! Finance]

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com
PDF Teva Pharmaceutical Industries' US$31.81 share price signals that it might be 45% undervalued Analyst price target for TEVA is US$35.32 which is 39% below our fair va [Read more]